Tripterygium wilfordii Glycosides Upregulate the New Anti-Inflammatory Cytokine IL-37 through ERK1/2 and p38 MAPK Signal Pathways

As a Chinese traditional patent medicine, Tripterygium wilfordii glycosides (TWG) have been approved by the China State Food and Drug Administration (Z32021007) for autoimmune and inflammatory diseases. Application of TWG leads to significant decrease of the inflammatory cytokines, such as IL-6, IL-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Evid Based Complement Alternat Med
Main Authors: Wang, Sen, Li, Rumeng, He, Suhui, He, Lingge, Zhao, Hang, Deng, Xiaohong, Chen, Zhangquan
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5748296/
https://ncbi.nlm.nih.gov/pubmed/29403538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/9148523
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados